Is vitamin E a safe prophylaxis for preeclampsia?
The prophylactic use of vitamins E and C for the prevention of preeclampsia is currently being evaluated in multiple clinical trials in Canada, Mexico, the United Kingdom, the United States, and other developing countries. In addition to its antioxidant capacity, exogenous vitamin E may prevent an immunologic switch (Th1 to Th2) that is vital for early-to late transition in normal pregnancies. Moreover, vitamin E could be a potential interferon-gamma (IFN-gamma) mimic facilitating persistent proinflammatory reactions at the fetal-maternal interface. These untoward effects of dietary intake of vitamin E may be more pronounced in those treated cases that fail to develop preeclampsia. A critical test of this hypothesis would be to establish whether, under variable O2 tension, vitamin E is capable of affecting cytokine signaling in placental trophoblasts and maternal immune effector cells, both in early and late human pregnancies.
Banerjee
Subhasis
S
Harris Birthright Research Centre for Fetal Medicine, King's College Hospital Medical School, London, UK. dr_sbanerjee@hotmail.com
Chambers
Anne E
AE
Campbell
Stuart
S
D000975:Antioxidants / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D014810:Vitamin E / Q000009:adverse effects* / Q000627:therapeutic use
D000975:Antioxidants; D014810:Vitamin E